Fresh twist over patent on Cancer Drug

The fight over the steeply priced cancer drug XTANDI(enzalutamide), used in prostate cancer has taken interesting turn, with a clutch of civil society, organisations including Union for Affordable Cancer Treatment and Health Global Access Project, urging University of Califirnia to withdraw its case and cease efforts to obtain patent in India. The drug was [...]